- Home
- SMPL vs EWTX Comparison
SMPL vs EWTX Comparison
Compare SMPL & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMPL
- EWTX
- Stock Information
- Founded
- SMPL 2017
- EWTX 2017
- Country
- SMPL United States
- EWTX United States
- Employees
- SMPL N/A
- EWTX N/A
- Industry
- SMPL Packaged Foods
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- SMPL Consumer Staples
- EWTX Health Care
- Exchange
- SMPL Nasdaq
- EWTX Nasdaq
- Market Cap
- SMPL 3.4B
- EWTX 3.3B
- IPO Year
- SMPL 2016
- EWTX 2021
- Fundamental
- Price
- SMPL $37.36
- EWTX $32.87
- Analyst Decision
- SMPL Buy
- EWTX Strong Buy
- Analyst Count
- SMPL 9
- EWTX 5
- Target Price
- SMPL $39.67
- EWTX $40.40
- AVG Volume (30 Days)
- SMPL 833.0K
- EWTX 721.8K
- Earning Date
- SMPL 01-02-2025
- EWTX 11-07-2024
- Dividend Yield
- SMPL N/A
- EWTX N/A
- EPS Growth
- SMPL 4.55
- EWTX N/A
- EPS
- SMPL 1.38
- EWTX N/A
- Revenue
- SMPL $1,331,321,000.00
- EWTX N/A
- Revenue This Year
- SMPL $11.84
- EWTX N/A
- Revenue Next Year
- SMPL $6.18
- EWTX N/A
- P/E Ratio
- SMPL $27.04
- EWTX N/A
- Revenue Growth
- SMPL 7.13
- EWTX N/A
- 52 Week Low
- SMPL $30.00
- EWTX $5.93
- 52 Week High
- SMPL $43.00
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- SMPL 70.59
- EWTX 53.15
- Support Level
- SMPL $36.29
- EWTX $34.39
- Resistance Level
- SMPL $37.16
- EWTX $38.12
- Average True Range (ATR)
- SMPL 0.59
- EWTX 1.85
- MACD
- SMPL 0.30
- EWTX -0.53
- Stochastic Oscillator
- SMPL 94.37
- EWTX 25.88
About SMPL The Simply Good Foods Company
The Simply Good Foods Co is a consumer packaged food and beverage company. It provides low-carbohydrate, high protein bars, shakes, and other products such as confections, chips, and cookies under the Atkins and Quest brands. The company distributes its products in retail channels, predominantly in North America, including grocery, club, and mass merchandise, as well as through e-commerce, convenience, and other channels.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.